Eli Lilly and Company's Fiscal Year is From January To December - All Figures are in Percent.
The item "Gross-Profit-Margin" stands at 83.03 percent as of 09/30/2025, the highest value at least since 06/30/2022, the period currently displayed.
As of the end of Eli Lilly and Company's third quarter, the item "Gross Profit Margin" stands at 83.03 Percent. This represents an increase of 0.39 percentage points compared to it's value at the end of it's second quarter .
Regarding the One-Year-Change of the series, the current value constitutes an increase of 2.12 percentage points compared to the value the year prior.
The 1 year change in percentage points is 2.12.
The 3 year change in percentage points is 7.42.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Johnson & Johnson - Gross Profit Margin | 486,508,953,600.00 |
![]() | AbbVie Inc - Gross Profit Margin | 399,570,305,024.00 |
![]() | Roche Holding AG - Gross Profit Margin | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Gross Profit Margin | 280,205,508,085.11 |
![]() | Novartis AG - Gross Profit Margin | 255,096,620,580.91 |